Florica Therapeutics, Inc. is pleased to announce being selected to participate in the National Science Foundation Innovation Corps (I-Corps) national program. The NSF I-Corps program is an intensive seven-week innovation and entrepreneurship training course aimed at identifying product-market fit. Recipients are provided with training, mentorship and $20,000 in NSF funding.
“We are immensely grateful to the National Science Foundation for their continued support in the commercialization of scientific innovation,” said Dr. Christine Ichim, CEO of Florica Therapeutics, Inc.
The team consists of:
Dr. Christine Ichim as Technical Lead. Dr. Ichim is the founder and CEO of Florica Therapeutics, Inc. She has a PhD from the University of Toronto and postdoctoral training from the Salk Institute and Lawrence Berkeley National Lab. Dr. Ichim is a serial entrepreneur with 20 years of experience in the molecular biology of stem cells. She is Principle Investigator on a Phase I NSF SBIR grant and was one of 40 startup founders selected out of 40,000 competitors to receive the Y Combinator Startup School grant.
Mr. Terry Hogue as Entrepreneurial Lead. Mr. Hogue is Employee #1 at Florica Therapeutics, Inc. working in the capacity of clinical liaison, executive and even as a bench scientist. Mr. Hogue has a broad range of clinical experience as a retired Paramedic Captain with the San Francisco Fire Department that is invaluable in his position as EL. Having spent a lifetime interacting with medical professionals he is able to relate to medical doctors with an ease that few academicians possess.
Mr. Sebastian Wong as the Mentor. Mr. Wong is investor #1 at Florica Therapeutics, Inc. and an advisor. Mr. Wong has over 35 years experience managing people, projects, budgets and timelines in the medical space. As a retired Paramedic Captain with the San Francisco Fire Department. Mr. Wong has successfully spearheaded a number of cross disciplinary multi-level initiatives in the Bay Area, expertly navigating the challenges of interfacing with highly hierarchical organizations.